Literature DB >> 20921426

New recommendations for treating hypertension in black patients: evidence and/or consensus?

Jackson T Wright, Lawrence Y Agodoa, Lawrence Appel, William C Cushman, Anne L Taylor, Gbenga G Obegdegbe, Kwame Osei, James Reed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20921426      PMCID： PMC2997473          DOI： 10.1161/HYPERTENSIONAHA.110.159566

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

1.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Authors:  Keith Norris; Jacque Bourgoigne; Jennifer Gassman; Lee Hebert; John Middleton; Robert A Phillips; Otelio Randall; Stephen Rostand; Susan Sherer; Robert D Toto; Jackson T Wright; Xuelei Wang; Tom Greene; Lawrence J Appel; Julia Lewis
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

3.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

4.  Effects of medical therapies on retinopathy progression in type 2 diabetes.

Authors:  Emily Y Chew; Walter T Ambrosius; Matthew D Davis; Ronald P Danis; Sapna Gangaputra; Craig M Greven; Larry Hubbard; Barbara A Esser; James F Lovato; Letitia H Perdue; David C Goff; William C Cushman; Henry N Ginsberg; Marshall B Elam; Saul Genuth; Hertzel C Gerstein; Ulrich Schubart; Lawrence J Fine
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

5.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

6.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

7.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

Authors:  Kenneth Jamerson; Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Victor Shi; Allen Hester; Jitendra Gupte; Marjorie Gatlin; Eric J Velazquez
Journal:  N Engl J Med       Date:  2008-12-04       Impact factor: 91.245

Review 8.  Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.

Authors:  Robert W Schrier; Raymond O Estacio; Philip S Mehler; William R Hiatt
Journal:  Nat Clin Pract Nephrol       Date:  2007-08

9.  ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

Authors:  Jackson T Wright; Jeffrey L Probstfield; William C Cushman; Sara L Pressel; Jeffrey A Cutler; Barry R Davis; Paula T Einhorn; Mahboob Rahman; Paul K Whelton; Charles E Ford; L Julian Haywood; Karen L Margolis; Suzanne Oparil; Henry R Black; Michael H Alderman
Journal:  Arch Intern Med       Date:  2009-05-11

10.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Authors:  Paolo Verdecchia; Jan A Staessen; Fabio Angeli; Giovanni de Simone; Augusto Achilli; Antonello Ganau; Gianfrancesco Mureddu; Sergio Pede; Aldo P Maggioni; Donata Lucci; Gianpaolo Reboldi
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321
View more
  6 in total

1.  Should African Americans have a lower blood pressure goal than other ethnic groups to prevent organ damage?

Authors:  John M Flack; Tochukwi Okwuosa; Rajeev Sudhakar; Brian Ference; Phillip Levy
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

Review 2.  African Americans, hypertension and the renin angiotensin system.

Authors:  Sandra F Williams; Susanne B Nicholas; Nosratola D Vaziri; Keith C Norris
Journal:  World J Cardiol       Date:  2014-09-26

Review 3.  Hypertensive chronic kidney disease in African Americans: strategies for improving care.

Authors:  David Martins; Lawrence Agodoa; Keith C Norris
Journal:  Cleve Clin J Med       Date:  2012-10       Impact factor: 2.321

Review 4.  The Case for Low Blood Pressure Targets.

Authors:  John M Flack; Carlos Nolasco; Phillip Levy
Journal:  Am J Hypertens       Date:  2016-08-29       Impact factor: 2.689

5.  Differential treatment of hypertension by primary care providers and hypertension specialists in a barber-based intervention trial to control hypertension in Black men.

Authors:  Florian Rader; Robert M Elashoff; Sara Niknezhad; Ronald G Victor
Journal:  Am J Cardiol       Date:  2013-08-23       Impact factor: 2.778

6.  Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence.

Authors:  Michael J Bloch; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-13       Impact factor: 3.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.